Treating Interdialytic Hyperkalemia with Fludrocortisone

Seminars in Dialysis

Volumn 16, Issue 1, 2003, Pages 5-7

  Imbriano, Louis J ^a   Durham, John H ^a   Maesaka, John K ^a  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; FLUDROCORTISONE; HYDROCORTISONE; MINERALOCORTICOID; POTASSIUM; PREDNISONE;

COLON ABSORPTION; FECES ANALYSIS; HEMODIALYSIS; HOMEOSTASIS; HUMAN; HYPERKALEMIA; HYPOTENSION; KIDNEY FAILURE; POTASSIUM BLOOD LEVEL; POTASSIUM CELL LEVEL; POTASSIUM EXCRETION; REVIEW; TOTAL BODY POTASSIUM; UPREGULATION; BLOOD; CHRONIC KIDNEY FAILURE; EDITORIAL; PHYSIOLOGY; RENAL REPLACEMENT THERAPY;

FLUDROCORTISONE; HUMANS; HYPERKALEMIA; KIDNEY FAILURE, CHRONIC; MINERALOCORTICOIDS; POTASSIUM; RENAL DIALYSIS;

EID: 0037643604     PISSN: 08940959     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-139X.2003.03002.x     Document Type: Review

References (49)

1. Perez GO, Pelleya R, Oster JR, Kem DC, Vaamonde CA: Blunted kaliuresis after an acute potassium load in patients with chronic renal failure. Kidney Int 24:656-662, 1983
2. Cox M, Sterns RH, Singer I: The defense against hyperkalemia: the roles of insulin and aldosterone. N Engl J Med 299:525-531, 1978
3. Textor SC, Bravo EL, Fouad FM, Tarazi RC: Hyperkalemia in azotemic patients during angiotensin-converting enzyme inhibition and aldosterone reduction with captopril. Am J Med 73:719-725, 1982
4. Busch AE, Suessbrach H, Kunzelmann H, Hipper A, Greger R, Waldegger S, Mutschler E, Lindermann B, Lang F: Blockade of epithelial Na+ channels by triamterene: underlying mechanism and molecular basis. Flugers Arch 432:760-766, 1996
5. AdrizaBalaga P, Montoliu J, Martinez Vea A, Andreu L, Lopez Pedret J, Revert L: Increase in serum potassium caused by beta-2 adrenergic blockade in terminal renal failure; absence of mediation by insulin or aldosterone. Proc Eur Dial Transplant Assoc 20:572-576, 1983
6. Struthers AD, Reid JL, Whitesmith R, Rodger JC: The effects of cardioselective and non-selective beta-adrenoreceptor blockade on the hypokalemic and cardiovascular responses to adreno-medullary hormones in man. Clin Sci 65:143-147, 1983
7. Whelton A, Hamilton CW: Nonsteroidal anti-inflammatory drugs: effects on kidney function. J Clin Pharmacol 31:588-598, 1991
8. Hottelart C, Archard JM, Moriniere P, Zoghbi F, Dieval J, Fournier A: Heparin-induced hyperkalemia in chronic hemodialysis patients: comparison of low molecular weight and unfractionated heparin. Artif Organs 22: 614-617, 1998
9. Gifford JD, Rutsky EA, Kirk KA, McDaniel HG: Control of serum potassium during fasting in patients with end-stage renal disease. Kidney Int 35:90-94, 1989
10. Kamel KS, Quaggin S, Scheich A, Halperin ML: Disorders of potassium homeostasis: an approach based on pathophysiology. Am J Kidney Dis 24:597-613, 1994
11. Young DB, Jackson TE: Effects of aldosterone on potassium distribution. Am J Physiol 243:R526-R530, 1982
12. Rosa RM, Silva P, Young JB, Landsberg L, Brown RS, Rowe JW, Epstein FH: Adrenergic modulation of extrarenal potassium disposal. N Engl J Med 302:431-434, 1980
13. DeFronzo RA, Bia M, Birkhead G: Epinephrine and potassium homeostasis. Kidney Int 20:83-91, 1981
14. Johnson MD, Kinter LB, Beeuwkes R: Effect of AVP and DDAVP on plasma renin activity and electrolyte excretion in conscious dogs. Am J Physiol 236:F66-F70, 1979
15. Barraclough MA, Jones NF: The effect of vasopressin on the reabsorption of sodium, potassium and urea by the renal tubules in man. Clin Sci 39:517-527, 1970
16. Uete T, Venning EH: Interplay between various adrenal cortical steroids with respect to electrolyte excretion. Endocrinology 71:768-778, 1962
17. Giebish GJ, Field MJ: Hormonal control of renal potassium excretion. Kidney Int 27:379-387, 1985
18. Good DW, Wright FS: Luminal influences on potassium secretion: sodium concentration and fluid flow rate. Am J Physiol 236:F192-F205, 1979
19. Bia MJ, DeFronzo RA: Extrarenal potassium homeostasis. Am J Physiol 240:F257-F287, 1981
20. Their SO. Potassium physiology. Am J Med 80(suppl 4A):3-7, 1986
21. Weiner ID, Wingo CS: Hyperkalemia: a potential silent killer. J Am Soc Nephrol 9:1535-1543, 1998
22. Conn JW: Aldosteronism in man. JAMA 183:134-141, 1963
23. Kahn T, Kaji DM, Nicholis G, Krakoff LR, Stein RM: Factors related to potassium transport in chronic stable renal disease in man. Clin Sci Mol Med 54:661-666, 1978
24. Fernandez J, Oster JR, Perea GO: Impaired extrarenal disposal of an acute oral potassium load in patients with end-stage renal disease on chronic hemodialysis. Miner Electrolyte Metab 12:125-129, 1986
25. Kim HJ: Combined effect of bicarbonate and insulin with glucose in acute therapy of hyperkalemia in end-stage renal disease patients. Nephron 72:476-482, 1996
26. Sherman RA, Hwang ER, Bernholc AS, Eisinger RP: Variability in potassium removed by hemodialysis. Am J Nephrol 6:284-288, 1986
27. Blumberg JA, Weidmann P, Shaw S, Gnadinger M: Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failure. Am J Med 85:507-512, 1988
28. Weigand DF, Davin TD, Raij L, Kjelstrand CM: Severe hypokalemia induced by hemodialysis. Arch Intern Med 141:167-170, 1981
29. Ward RA, Warthen RL, Williams TE, Harding GB: Hemodialysis composition and intradialytic metabolic, acid-base and potassium changes. Kidney Int 32:129-135, 1987
30. Morrison G, Michelson EL, Brown S, Morganroth J: Mechanism and prevention of cardiac arrhythmias in chronic hemodialysis patients. Kidney Int 17:811-819, 1980
31. Hou S, McElroy PA, Nootes S, Beach M: Safety and efficacy of low potassium dialysate. Am J Kidney Dis 13:137-141, 1989
32. Karnik JA, Young BS, Lew NL, Herget M, Dubinsky C, Lazarus JM, Chertow GM: Cardiac arrest and sudden death in dialysis units. Kidney Int 60:350-357, 2001
33. Jenkins HR, Genton TR, McIntosh N, Dilon MJ, Milla PJ: Development of colonic sodium transport in early childhood and its regulation by aldosterone. Gut 31:194-197, 1990
34. Lomax RB, Sandle GI: Comparison of aldosterone and RU-28362-induced apical Na+ and K+ conductances in rat distal colon. Am J Physiol 267:G485-G493, 1994
35. Turnamian SG, Binder HJ: Aldosterone and glucocorticoid receptor-specific agonists regulate ion transport in rat proximal colon. Am J Physiol 258:G492-G498, 1990
36. Techkemmer G, Halm RD: Aldosterone stimulates K+ secretion across mammalian colon independent of Na+ absorption. Proc Natl Acad Sci USA 86:397-401, 1989
37. Hayes CJP, McLeod ME, Robinson RR: An extrarenal mechanism for the maintenance of potassium balance in severe chronic renal failure. Trans Assoc Am Physicians 80:207-221, 1967
38. Shustin L, Wald H, Popovtzer MM: Role of down-regulated CHIF-mRNA in the pathophysiology of hyperkalemia of acute tubular necrosis. Am J Kidney Dis 32:600-604, 1998
39. McCabe RD, Smith MJ, Dwyer TM: Faecal dry weight and potassium are related to faecal sodium and plasma aldosterone in rats chronically fed on varying amounts of sodium or potassium chlorides. Br J Nutr 72:325-327, 1994
40. Wilson RD, Ing TS, Metcalfe-Gibson A, Wrong OM: The chemical composition of faeces in uraemia as revealed by in-vivo faecal dialysis. Clin Sci 35:197-209, 1968
41. Gerstein AR, Kleeman CR, Gold EM, Franklin SS, Maxwell MH, Gonick HC, Feffer ML, Steinman TI: Aldosterone deficiency in chronic renal failure. Nephron 5:90-105, 1968
42. Drug Facts and Comparisons, St. Louis, MO: Wolters-Kluwer, 2001:333 (also available at http://www.drugfacts.com)
43. Sebastian A, Schambelan M, Lindenfeld S, Morris RC: Amelioration of metabolic acidosis with fludrocortisone therapy in hyporeninemic hypoaldosteronism. N Engl J Med 297:576-582, 1977
44. Dreyling KW, Wanner CJ, Schollmeyer P: Control of hyperkalemia with fludrocortisone in a patient with systemic lupus erythematosus. Clin Nephrol 33:179-183, 1990
45. Sherman DS, Kass CL, Fish DN: Fludrocortisone for the treatment of heparin-induced hyperkalemia. Ann Pharmacother 34:606-610, 2000
46. Sandle G, Gaiger JE, Ptapster S, Goodship T: Enhanced rectal potassium secretion in chronic renal insufficiency: evidence for large intestinal potassium adaptation in man. Clin Sci 71:393-401, 1986
47. Hottelart C, Archard JM, Moriniere P, Zoghbi JFJ, Dieval J, Fournier A: Heparin-induced hyperkalemia in chronic hemodialysis patients: comparison of low molecular weight and unfractionated heparin. Artif Organs 22:614-617, 1998
48. Nyman N, Mulgaonkar S, Walcer R, Viscuso R, Jacobs MG: Effects of a mineralocorticoid on extra-renal potassium (K +) homeostasis in anuric patients. Kidney Int 23:155A, 1983
49. Singhal PC, Desroches L, Mattana J, Abramovici M, Wagner JD, Maesaka JK: Mineralocorticoid therapy lowers serum potassium in patients with end-stage renal disease. Am J Nephrol 13:138-141, 1993